| Title |
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
|
|---|---|
| Published in |
Osteoporosis International, January 2012
|
| DOI | 10.1007/s00198-011-1870-0 |
| Pubmed ID | |
| Authors |
R. Rizzoli, J. J. Body, A. De Censi, J. Y. Reginster, P. Piscitelli, M. L. Brandi, on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO) |
| Abstract |
Aromatase inhibitors (AIs) are widely used in women with breast cancer, but they are known to increase bone loss and risk of fractures. Based on available evidence and recommendations, an ESCEO working group proposes specific guidance for the prevention of AIs-induced bone loss and fragility fractures. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Unknown | 114 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 11 | 10% |
| Student > Master | 11 | 10% |
| Researcher | 10 | 9% |
| Student > Bachelor | 10 | 9% |
| Student > Doctoral Student | 9 | 8% |
| Other | 36 | 31% |
| Unknown | 28 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 46% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 7% |
| Nursing and Health Professions | 6 | 5% |
| Agricultural and Biological Sciences | 3 | 3% |
| Engineering | 2 | 2% |
| Other | 10 | 9% |
| Unknown | 33 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2012.
All research outputs
#18,304,874
of 22,663,150 outputs
Outputs from Osteoporosis International
#2,708
of 3,596 outputs
Outputs of similar age
#196,294
of 246,018 outputs
Outputs of similar age from Osteoporosis International
#24
of 41 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,596 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,018 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.